首页 | 本学科首页   官方微博 | 高级检索  
     

����NO�����N-����-1H-��������ṹ����������,�ϳɼ�����Ѫѹ�����о�
引用本文:���޴�,Ҧ��Ȩ,�ܽ���,������,����. ����NO�����N-����-1H-��������ṹ����������,�ϳɼ�����Ѫѹ�����о�[J]. 中国药学杂志, 2015, 50(24): 2160-2165. DOI: 10.11669/cpj.2015.24.016
作者姓名:���޴�  Ҧ��Ȩ  �ܽ���  ������  ����
作者单位:1. ??????????????,??????????????????о???,??? 230038;
2.?й????????????????,??? 210009
摘    要:

关 键 词:N-????-1H-????????  NO????  AT1?????????   ??????  

Design,Synthesis and Evaluation of Antihypertensive Activity of Novel Nitric Oxide-Releasing N-Phenyl-1H-Pyrrole Derivatives
ZHANG Yan-chun,YAO He-quan,ZHOU Jin-pei,WU Xiao-ming,XU Jin-yi. Design,Synthesis and Evaluation of Antihypertensive Activity of Novel Nitric Oxide-Releasing N-Phenyl-1H-Pyrrole Derivatives[J]. Chinese Pharmaceutical Journal, 2015, 50(24): 2160-2165. DOI: 10.11669/cpj.2015.24.016
Authors:ZHANG Yan-chun  YAO He-quan  ZHOU Jin-pei  WU Xiao-ming  XU Jin-yi
Affiliation:1. Anhui Academy of Chinese Medicine, Medicinal Chemestry Department,Anhui University of Chinese Medicine, Hefei 230012, China;
2.Department of Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China
Abstract:??OBJECTIVE To synthesize and evaluate of antihypertensive activity of novel nitric oxide-releasing N-phenyl-1H-pyrrole derivatives. METHODS By connecting key structural elements present in an AT1 receptor antagonist irbesartan with N-phenyl-1H-pyrrole carboxylic acid, a novel AT1 antagonist compound 4 was designed and synthesized, and a series of novel NO-donating derivatives (IN 1-10) were obtained by introducing NO donor. The amount of NO production in vitro of the target compounds were determined by Greiss assay. And the antagonism of Ang II induced vascular contraction assay was used to value the inhibition rate. RESULTS The antagonism of Ang ?? induced vascular contraction assay indicated that the novel compound exhibited similar activity as losartan. The NO derivative, compound IN9, found to release the maximum amount of NO during the NO releasing assay, was more potent than the lead compound 4 and positive control losartan. CONCLUSION These date indicate that the improved activities of these hybrid molecules contribute to the NO donor and the protection ability of NO donor make them promising candidates as antihypertensive agents.
Keywords:
点击此处可从《中国药学杂志》浏览原始摘要信息
点击此处可从《中国药学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号